130 related articles for article (PubMed ID: 38538070)
1. Lentinan inhibits cell invasion via M2 polarization of tumor-associated macrophages and Wnt/β-catenin signaling in non-small cell lung cancer.
Yang Y; Cheng Y; Mu Y; Tang X; Mu X
Chem Biol Drug Des; 2024 Mar; 103(3):e14507. PubMed ID: 38538070
[TBL] [Abstract][Full Text] [Related]
2. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
3. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
Lv J; Chen FK; Liu C; Liu PJ; Feng ZP; Jia L; Yang ZX; Hou F; Deng ZY
Life Sci; 2020 Sep; 256():117925. PubMed ID: 32522570
[TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
6. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
7. BCL9 promotes epithelial mesenchymal transition and invasion in cisplatin resistant NSCLC cells via β-catenin pathway.
Zhang Y; Zhang Q; Chen H; Wang C
Life Sci; 2018 Sep; 208():284-294. PubMed ID: 30009824
[TBL] [Abstract][Full Text] [Related]
8. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
9. M2-like tumor-associated macrophages-secreted Wnt1 and Wnt3a promotes dedifferentiation and metastasis via activating β-catenin pathway in thyroid cancer.
Lv J; Feng ZP; Chen FK; Liu C; Jia L; Liu PJ; Yang CZ; Hou F; Deng ZY
Mol Carcinog; 2021 Jan; 60(1):25-37. PubMed ID: 33283877
[TBL] [Abstract][Full Text] [Related]
10. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
[TBL] [Abstract][Full Text] [Related]
11. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
Qu L; Tian Y; Wang F; Li Z
BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
[TBL] [Abstract][Full Text] [Related]
12. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
[TBL] [Abstract][Full Text] [Related]
13. Porcupine inhibitor LGK‑974 inhibits Wnt/β‑catenin signaling and modifies tumor‑associated macrophages resulting in inhibition of the malignant behaviors of non‑small cell lung cancer cells.
Tang Y; Jiang M; Chen A; Qu W; Han X; Zuo J; Xu G; Song Y; Chen C; Ke X
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080032
[TBL] [Abstract][Full Text] [Related]
14. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt/β-catenin by targeting HOXA1.
Han W; Ren X; Yang Y; Li H; Zhao L; Lin Z
Thorac Cancer; 2020 Jun; 11(6):1679-1688. PubMed ID: 32364673
[TBL] [Abstract][Full Text] [Related]
15. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein receptor-related protein 8 facilitates the proliferation and invasion of non-small cell lung cancer cells by regulating the Wnt/β-catenin signaling pathway.
Fang Z; Zhong M; Zhou L; Le Y; Wang H; Fang Z
Bioengineered; 2022 Mar; 13(3):6807-6818. PubMed ID: 35246020
[TBL] [Abstract][Full Text] [Related]
17. TRIM27 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer through SIX3-β-catenin signaling.
Liu S; Tian Y; Zheng Y; Cheng Y; Zhang D; Jiang J; Li S
Aging (Albany NY); 2020 Dec; 12(24):25564-25580. PubMed ID: 33264103
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
Singh T; Katiyar SK
PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
[TBL] [Abstract][Full Text] [Related]
20. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
Wang T; Liu X; Tian Q; Liang T; Chang P
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
